ADAP
Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
$87
About Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Details
Daily high
$0.91
Daily low
$0.86
Price at open
$0.89
52 Week High
$2.05
52 Week Low
$0.42
Market cap
224.8M
Dividend yield
0.00%
Volume
482,567
Avg. volume
1.1M
P/E ratio
-2.54
Adaptimmune Therapeutics plc American Depositary Shares News
Details
Daily high
$0.91
Daily low
$0.86
Price at open
$0.89
52 Week High
$2.05
52 Week Low
$0.42
Market cap
224.8M
Dividend yield
0.00%
Volume
482,567
Avg. volume
1.1M
P/E ratio
-2.54